» Articles » PMID: 47015

Faecal Bile-acids and Clostridia in Patients with Cancer of the Large Bowel

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 1975 Mar 8
PMID 47015
Citations 75
Authors
Affiliations
Soon will be listed here.
Abstract

Of 44 patients with cancer of the large bowel, 36 ( 82%) had high faecal bile-acid concentrations compared with only 15 (17%) out of 90 patients with other diseases. 31 (70%) of the 44 patients with large-bowel cancer had high faecal bile-acid concentrations in the presence of faecal clostridia able to dehydrogenate the bile-acid nucleus, compared with only 8 (9%) out of 90 patients with other diseases. Thes findings support the hypothesis that cancer of the large bowel is caused by high concentrations of bile-acid derivatives produced by certain anaerobic bacteria.

Citing Articles

The effect of fecal bile acids on the incidence and risk-stratification of colorectal cancer: an updated systematic review and meta-analysis.

Yang S, Wang Y, Sheng L, Cui W, Ma C Sci Rep. 2025; 15(1):740.

PMID: 39753873 PMC: 11698987. DOI: 10.1038/s41598-024-84801-6.


A Narrative Review: Immunometabolic Interactions of Host-Gut Microbiota and Botanical Active Ingredients in Gastrointestinal Cancers.

Li S, Feng W, Wu J, Cui H, Wang Y, Liang T Int J Mol Sci. 2024; 25(16).

PMID: 39201782 PMC: 11354385. DOI: 10.3390/ijms25169096.


Association between diverticular disease and colorectal cancer: a bidirectional mendelian randomization study.

Zhang Y, Zhang H, Zhu J, He Y, Wang P, Li D BMC Cancer. 2023; 23(1):137.

PMID: 36765336 PMC: 9912649. DOI: 10.1186/s12885-023-10606-x.


Benign gallbladder disease is a risk factor for colorectal cancer, but cholecystectomy is not: A propensity score matching analysis.

Qin Q, Li W, Ren A, Luo R, Luo S Front Oncol. 2022; 12:1008394.

PMID: 36568240 PMC: 9773875. DOI: 10.3389/fonc.2022.1008394.


Late-Stage Glioma Is Associated with Deleterious Alteration of Gut Bacterial Metabolites in Mice.

Herbreteau A, Aubert P, Croyal M, Naveilhan P, Billon-Crossouard S, Neunlist M Metabolites. 2022; 12(4).

PMID: 35448477 PMC: 9028041. DOI: 10.3390/metabo12040290.